Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis

Published:2007-12-14 Issue:2 Volume:23 Page:310-315
ISSN:0268-1161
Container-title:Human Reproduction
language:en
Short-container-title:Human Reproduction

Author:

Coomarasamy A.,Afnan M.,Cheema D.,van der Veen F.,Bossuyt P. M.M.,van Wely M.

Publisher

Oxford University Press (OUP)

Subject

Obstetrics and Gynecology,Rehabilitation,Reproductive Medicine

Link

http://academic.oup.com/humrep/article-pdf/23/2/310/1740092/dem305.pdf

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Luteinizing hormone supplementation with human menopausal gonadotropin versus low dose human chorionic gonadotropin during ovarian stimulation does not affect live birth rates after fresh and frozen embryo transfer;Journal of Obstetrics and Gynaecology Research;2024-09-08

2. Interventions to prevent or reduce the incidence and severity of ovarian hyperstimulation syndrome: a systematic umbrella review of the best clinical evidence;Reproductive Biology and Endocrinology;2023-07-21

3. Introduce an optimal method of ovarian stimulation in the polycystic ovarian syndrome affected: a randomized controlled trial;BMC Women's Health;2023-06-20

4. Highly purified-hMG versus rFSH in ovarian hyperstimulation in women undergoing elective fertility preservation;2023-02-13

5. Follicle-stimulating hormone (and luteinizing hormone) in ovarian stimulation: Does the dose matter for cycle success?;Fertility and Sterility;2023-02